Dimension Therapeutics, Inc. Assets, Fair Value Disclosure
Dimension Therapeutics, Inc. had Assets, Fair Value Disclosure of $33.72 million as of 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2017-11-06
- 2017-09-30: Assets, Fair Value Disclosure $33.72M.
- 2017-06-30: Assets, Fair Value Disclosure $47.49M.
- 2017-03-31: Assets, Fair Value Disclosure $59.14M.
- 2016-12-31: Assets, Fair Value Disclosure $77.95M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2017-09-30 | $33.72M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $47.49M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $59.14M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $77.95M 10-Q · filed 2017-11-06 |
| 2016-09-30 | $93.75M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $104.65M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $117.03M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $127.05M 10-Q · filed 2016-08-11 |
| 2015-09-30 | $69.25M 10-Q · filed 2015-12-04 |
| 2014-12-31 | $17.84M 10-K · filed 2016-03-24 |